Gene Polymorphisms Of Vascular Endothelial Growth Factor And The Susceptibility To Osteosarcoma In Chinese Population: A Meta-Analysis

Fangteng Liu,Peiqian Zhu,Liang Zhou,Guangfeng Xia,Yi Zhang,Hongliang Luo,Zhengming Zhu
2016-01-01
Abstract:Osteosarcoma (OS) is a kind of malignant bone tumor accounting for similar to 6% of all cancer in children. The precise mechanism of occurrence and development of OS remains under investigation. Vascular endothelial growth factor (VEGF), known for the role as a key mediator of angiogenesis, has been shown to have some associations with a variety of malignant tumors, including OS. VEGF gene polymorphisms may involve in the carcinogenesis by influencing the formation of blood vessels. In order to estimate the correlation between VEGF gene polymorphisms and the risk of OS, we performed the meta-analysis based on five case-control studies from PubMed and CNKI. The results of this study indicated that in Chinese populations, the VEGF 1612G/A, -1156G/A gene polymorphisms are not associated with the susceptibility to OS and the -2578C/A and -460T/C gene polymorphism are associated with the risk of OS, and for -634G/C and -936C/T, there may be exist an association in OS risk. Due to the limitations of this study, further larger-size, multi-center and higher-quality case-control studies are warranted to validate our findings.
What problem does this paper attempt to address?